Spots Global Cancer Trial Database for 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
Official Title: Randomised Phase II Study of Neoadjuvant BIBW 2992 Versus Herceptin Versus Lapatinib in Her2 Positive Breast Cancer Patients
Study ID: NCT00826267
Conditions
Study Description
Brief Summary: An open-label, randomized three-arm Phase II trial to explore the efficacy of BIBW 2992 as a single agent versus lapatinib versus trastuzumab in patients with HER2-positive treatment-naïve Stage IIIa locally advanced breast cancer. Additional information will be obtained on the safety profile and pharmacokinetics of BIBW 2992.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
1200.44.01001 Boehringer Ingelheim Investigational Site, Houston, Texas, United States
1200.44.12008 Boehringer Ingelheim Investigational Site, Brasilia, , Brazil
1200.44.12011 Boehringer Ingelheim Investigational Site, Cachoeiro de Itapemirim, , Brazil
1200.44.12012 Boehringer Ingelheim Investigational Site, Campo Grande, , Brazil
1200.44.12009 Boehringer Ingelheim Investigational Site, Caxias do Sul, , Brazil
1200.44.12010 Boehringer Ingelheim Investigational Site, Goiania, , Brazil
1200.44.12005 Boehringer Ingelheim Investigational Site, Ijui, , Brazil
1200.44.12007 Boehringer Ingelheim Investigational Site, Natal, , Brazil
1200.44.12004 Boehringer Ingelheim Investigational Site, Novo Hamburgo, , Brazil
1200.44.12001 Boehringer Ingelheim Investigational Site, Porto Alegre, , Brazil
1200.44.12013 Boehringer Ingelheim Investigational Site, Porto Alegre, , Brazil
1200.44.14002 Boehringer Ingelheim Investigational Site, Bogotá, , Colombia
1200.44.14001 Boehringer Ingelheim Investigational Site, Cali, , Colombia
1200.44.19005 Boehringer Ingelheim Investigational Site, Cercado, , Peru
1200.44.19001 Boehringer Ingelheim Investigational Site, Lima, , Peru
1200.44.19004 Boehringer Ingelheim Investigational Site, Lima, , Peru
1200.44.19003 Boehringer Ingelheim Investigational Site, San Isidro, , Peru
Contact Details
Name: Boehringer Ingelheim
Affiliation: Boehringer Ingelheim
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
